• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: Director Shepard William R bought $324,198 worth of Common Stock Class A (1,422 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

    3/27/25 6:55:07 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    SEC FORM 4/A SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    SHEPARD WILLIAM R

    (Last) (First) (Middle)
    20 S WACKER DRIVE

    (Street)
    CHICAGO IL 60606

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CME GROUP INC. [ CME ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    01/16/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    01/17/2025
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock Class A 01/16/2025 P 1,362.12(1) A $227.96 256,798.43 I by Trust
    Common Stock Class A 01/16/2025 P 60.05(1) A $227.96 2,431.89 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The original Form 4 filed on January 17, 2025 is being amended to reflect an update in the number of shares acquired on January 16, 2025 pursuant to a dividend reinvestment plan administered by the reporting person's broker. Subsequent to the purchase and the filing of the original Form 4, an adjustment in the number of shares received by the reporting person was made by the broker. This Form 4/A is being filed to update the number of securities held directly and indirectly following this purchase. Actual amounts of fractional shares owned may vary slightly due to rounding.
    Remarks:
    By: Margaret Austin Wright For: William R. Shepard 03/27/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CME alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    10/8/2024$244.00Buy → Neutral
    Redburn Atlantic
    9/27/2024$235.00Sector Perform
    RBC Capital Mkts
    9/26/2024$221.00Hold
    TD Cowen
    9/3/2024$212.00 → $177.00Neutral → Underperform
    BofA Securities
    6/21/2024$206.00 → $187.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $CME
    SEC Filings

    See more
    • SEC Form 10-Q filed by CME Group Inc.

      10-Q - CME GROUP INC. (0001156375) (Filer)

      4/30/25 2:50:10 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form 144 filed by CME Group Inc.

      144 - CME GROUP INC. (0001156375) (Subject)

      4/25/25 4:28:42 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - CME GROUP INC. (0001156375) (Filer)

      4/25/25 9:10:59 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Shepard William R bought $71,995 worth of Common Stock Class A (274 units at $262.62), increasing direct ownership by 0.48% to 2,443 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 7:19:14 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Amendment: Director Shepard William R bought $324,198 worth of Common Stock Class A (1,422 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

      4/A - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 6:55:07 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Shepard William R bought $325,798 worth of Common Stock Class A (1,429 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      1/17/25 12:12:49 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Sr MD Gl Hd Commodities Mkts Sammann Derek disposed of 2,175 units of Common Stock Class A, acquired 2,175 units of Common Stock Class A and sold $1,304,847 worth of Common Stock Class A (4,650 units at $280.61), decreasing direct ownership by 19% to 9,417 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      5/7/25 6:16:41 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Amendment: Sr MD Gl Hd Commodities Mkts Sammann Derek was granted 3,883 units of Common Stock Class A and covered exercise/tax liability with 1,708 units of Common Stock Class A, increasing direct ownership by 23% to 11,592 units (SEC Form 4)

      4/A - CME GROUP INC. (0001156375) (Issuer)

      5/7/25 5:17:16 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Sammann Derek decreased direct ownership by 20% to 9,417 units (SEC Form 5)

      5 - CME GROUP INC. (0001156375) (Issuer)

      5/5/25 4:11:44 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded CME Group from Equal-Weight to Overweight and set a new price target of $301.00

      4/8/25 9:08:11 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group upgraded by Raymond James with a new price target

      Raymond James upgraded CME Group from Mkt Perform to Outperform and set a new price target of $287.00

      3/10/25 7:18:35 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group downgraded by Citigroup with a new price target

      Citigroup downgraded CME Group from Buy to Neutral and set a new price target of $250.00 from $255.00 previously

      1/6/25 7:45:08 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Financials

    Live finance-specific insights

    See more
    • CME Group Declares Quarterly Dividend

      CHICAGO, May 8, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a second-quarter dividend of $1.25 per share. The dividend is payable June 25, 2025 to shareholders of record as of June 9, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultu

      5/8/25 7:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2025

      Record revenue of $1.6 billion, up 10% from Q1 2024Record average daily volume (ADV) of 29.8 million contracts, with broad-based growth in every asset classCHICAGO, April 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the first quarter of 2025. The company reported revenue of $1.6 billion and operating income of $1.1 billion for the first quarter of 2025. Net income was $956 million and diluted earnings per common share were $2.62. On an adjusted basis, net income was $1.0 billion and diluted earnings per common share were $2.80. Financial results presented on an adjusted basis for the first quarter of 2025 and 2024 exclude certain items, which are

      4/23/25 7:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. Announces First-Quarter 2025 Earnings Release, Conference Call

      CHICAGO, March 12, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the first quarter of 2025 before the markets open on Wednesday, April 23, 2025. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.  A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site. Those wishing

      3/12/25 12:37:00 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CME Group Declares Quarterly Dividend

      CHICAGO, May 8, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a second-quarter dividend of $1.25 per share. The dividend is payable June 25, 2025 to shareholders of record as of June 9, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultu

      5/8/25 7:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Farmer sentiment improves as long-term optimism outweighs tariff concerns

      WEST LAFAYETTE, Ind., May 6, 2025 /PRNewswire/ -- Farmer sentiment improved in April as producers expressed more optimism about current and future conditions on their farms. The Purdue University/CME Group Ag Economy Barometer rose 8 points to a reading of 148, up from 140 in March. The Index of Current Conditions climbed 9 points to 141, while the Index of Future Expectations increased 8 points to 152. The improvement in sentiment came amid ongoing tensions with many of U.S. agriculture's largest trading partners, including Mexico and Canada. Notably, a majority of producers said they believe the increased use of tariffs will ultimately benefit the U.S. agricultural economy, a view reflecte

      5/6/25 9:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Sets New ADV Record of 35.9 Million Contracts In April, Up 36% Year Over Year

      Interest rate ADV grew 46% to 18.4 million contractsRecord monthly ADV in equity index and metals productsRecord monthly international ADV of 10.9 million contractsCHICAGO, May 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its April 2025 market statistics reached an all-time monthly average daily volume (ADV) record of 35.9 million contracts, an increase of 36% year-over-year. The company's interest rate ADV grew 46% to 18.4 million contracts in April, while its equity index and metals products set new monthly ADV records of 9.7 million contracts and 1 million contracts, respectively. CME Group also reached monthly volume records in SOFR futu

      5/2/25 7:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Leadership Updates

    Live Leadership Updates

    See more
    • CME Clearing Appoints New Chief Risk Officer

      CHICAGO, April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division.  With over 20 years' industry experience, Albuquerque most recently served as the Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses. Albuquerque will be based in New York and will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. "Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our

      4/24/25 4:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Sterling Trading Tech Names Julie Armstrong Chief Commercial Officer

      Chicago , April 23, 2025 (GLOBE NEWSWIRE) -- Sterling Trading Tech (Sterling), a leading global provider of technology in order management, risk and margin, and trading, announced today the appointment of Julie Armstrong as Chief Commercial Officer, a newly created role that underscores the firm's commitment to scaling its business globally. This strategic hire signals Sterling's transition into its next phase of accelerated growth, building on recent momentum across new client segments, product innovation, asset expansion, and geographic reach. Armstrong, a recognized industry expert, brings decades of experience in global fintech strategy and revenue generation. She will lead Sterling'

      4/23/25 2:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Appoints Mike Dennis as Global Head of Fixed Income

      CHICAGO, July 8, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Mike Dennis as Global Head, Fixed Income. In this position, Dennis will oversee the company's largest, most actively traded global benchmark futures and options contracts on SOFR and U.S. Treasuries, including the 30-year bond, 10-, 5- and 2-year notes that enable investors to manage risk across the entire U.S. yield curve. He will also lead BrokerTec, the world's most liquid electronic cash trading platform for U.S Treasury benchmarks, E.U., U.K. and U.S. Repo trading. Dennis will report to CME Group Chairman and Chief Executive Officer Terry Duffy and serve on th

      7/8/24 10:02:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/13/24 5:02:29 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/13/23 2:49:27 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/11/22 3:04:00 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance